Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Anticancer Research|April 7, 2019
Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point InhibitorJerome H Check, Diane Check, Trina PorettaFertility and Sterility|January 26, 2010
A method to improve false interpretation of the endometrial echo pattern as homogeneous hyperechogenicCarole Dietterich, Kathleen Klausner, Jerome H CheckAnticancer Research|November 29, 2025
Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With MifepristoneJerome H Check, Diane L Check, Carrie WilsonAnticancer Research|May 16, 2009
Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case reportJerome H Check, Ebony Dix, Lynn Sansoucie, et al.Fertility and Sterility|March 7, 2003
Evaluation of a nonhomogeneous endometrial echo pattern in the midluteal phase as a potential factor associated with unexplained infertilityJerome H Check, Regina Gandica, Carole Dietterich, et al.Anticancer Research|December 29, 2010
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studiesJerome H Check, Ebony Dix, Carrie Wilson, et al.Journal of Assisted Reproduction and Genetics|December 5, 2015
Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF)Rachael A Cohen, Jerome H Check, Michael P DoughertyAnticancer Research|April 4, 2021
Palliative Benefits of Oral Mifepristone for the Treatment of Metastatic Fibroblastic OsteosarcomaJerome H Check, Diane Check, Trina Poretta, et al.Anticancer Research|April 30, 2014
Evidence that Mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IVJerome H Check, Carrie Wilson, Rachael Cohen, et al.Anticancer Research|January 30, 2026
Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator MifepristoneJerome H Check, Diane L Check, Naomi Ganpo-NkewnkwaPageof 5